66 results match your criteria: "GlaxoWellcome Medicines Research Centre[Affiliation]"
Bioorg Med Chem Lett
February 1999
Department of Medicinal Chemistry, GlaxoWellcome Medicines Research Centre, Stevenage, Herts UK.
Synthesis of 5R-Acetamido-4S-amino-4H-pyran-6R-O-( -ethyl)propyl and 6R-(1-oxo-2-ethyl)butyl 2-carboxylic acids (4 and 5) and their evaluation as inhibitors of influenza virus sialidase is described. Both compounds showed good inhibitory activity with marked selectivity for influenza A sialidase.
View Article and Find Full Text PDFProtein Sci
February 1999
Advanced Technology and Informatics Unit, GlaxoWellcome Medicines Research Centre, Stevenage, United Kingdom.
Computer-based database searching and protein multiple sequence alignment has identified a novel clan of zinc metallopeptidases, which, by phylogenetic analysis, has been shown to contain six subfamilies. The family is characterized by four common transmembrane segments and three conserved sequence motifs. The combination of topology analysis and motif identification has detected three potential Zn2+ coordinating residues.
View Article and Find Full Text PDFBioinformatics
June 1999
Bioinformatics, Research Information Systems, GlaxoWellcome Medicines Research Centre, Stevenage, Herts SG1 2NY, UK.
Results: JavaShade is a multiple sequence alignment box-and-shade tool for generating high quality printed output that uses a variety of methods for boxing and shading, allowing the most appropriate functions to be chosen for displaying the most meaningful positions in an alignment.
Availability: JavaShade is available from the WWW at http://industry.ebi.
Eur J Neurosci
December 1998
Department of Pharmacology, GlaxoWellcome Medicines Research Centre, Verona, Italy.
Novel mRNA isoforms for two members of the group III metabotropic glutamate receptors (mGluRs), called mGluR7b and mGluR8b, were identified from rat brain cerebral cortex and hippocampus. In both cases, the alternative splicing is generated by a similar out-of-frame insertion in the carboxyl-terminus that results in the replacement of the last 16 amino acids of mGluR7 and mGluR8 by 23 and 16 different amino acids, respectively. Distribution analysis for mGluR7 and mGluR8 isoforms revealed that the two splice variants are generally coexpressed in the same brain areas.
View Article and Find Full Text PDFAlternative splicing has been shown to occur at the metabotropic glutamate receptor 1 (mGluR1) gene. Three main isoforms that differ in their carboxy-termini have been described so far and named mGluR1alpha, mGluR1beta and mGluR1c. These variants when expressed in recombinant systems all activate phospholipase C, although the [Ca2+] signals generated have different kinetics.
View Article and Find Full Text PDFJ Med Chem
October 1998
Enzyme Chemistry 2, Development Chemistry 3, Physical Sciences, and Enzyme Pharmacology, GlaxoWellcome Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, U.K.
Eur J Neurosci
March 1998
Neuroscience Unit, GlaxoWellcome Medicines Research Centre, Stevenage, Herts.
Early stage Alzheimer's disease (AD) pathology is associated with neurodegeneration of systems within the temporal cortex, e.g. the entorhinal cortex, perforant pathway and hippocampus.
View Article and Find Full Text PDFTrends Pharmacol Sci
August 1998
Receptor Pharmacology Unit, GlaxoWellcome Medicines Research Centre, Stevenage, UK.
J Pharm Biomed Anal
December 1997
Chemical Analysis Department, GlaxoWellcome Medicines Research Centre, Stevenage, UK.
Directly coupled HPLC NMR spectroscopic and HPLC-MS approaches have been used to confirm the identity of four known dimeric impurities in a partially purified batch of fluticasone propionate each at levels of 0.06-0.9% of parent compound based on UV absorption.
View Article and Find Full Text PDFJ Gen Virol
October 1997
Hepatitis Antiviral Research, Virology Research Unit, GlaxoWellcome Medicines Research Centre, Stevenage, Herts, UK.
J Biol Chem
August 1997
Glycobiology Unit, GlaxoWellcome Medicines Research Centre, Stevenage, Herts SG1 2NY, United Kingdom.
The lipopolysaccharide of certain strains of Helicobacter pylori was recently shown to contain the Lewis X (Lex) trisaccharide (Galbeta-1, 4-(Fucalpha(1,3))-GlcNAc). Lex is an oncofetal antigen which appears on human gastric epithelium, and its mimicry by carbohydrate structures on the surface of H. pylori may play an important part in the interaction of this pathogen with its host.
View Article and Find Full Text PDFNeuropharmacology
August 1997
Pharmacology Dept, GlaxoWellcome Medicines Research Centre, Verona, Italy.
Application of the metabotropic glutamate receptor (mGluR) agonist (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) and the Group I selective mGluR agonist (RS)-3,5-dihydroxyphenylglycine (DHPG) potentiated NMDA- and AMPA-induced potential changes recorded from ventral roots of the isolated hemisected baby rat spinal cord. Potentiation produced by 1S,3R-ACPD was completely abolished by the Group I selective mGluR antagonists (S)-4-carboxyphenylglycine (4CPG) or (+)-alpha-methyl-4-carboxyphenylglycine (MCPG). In addition, the protein kinase C (PKC) blockers staurosporine or chelerythrine chloride were able to antagonize the 1S,3R-ACPD-induced potentiation of both NMDA and AMPA response, suggesting that the enhancing effect induced by Group I mGluRs is modulated by a PKC-mediated mechanism.
View Article and Find Full Text PDFAnal Chem
June 1997
Department of Physical Sciences, GlaxoWellcome Medicines Research Centre, Stevenage, Herts, SG1 2NY, United Kingdom.
A new chromatographic hydrophobicity index (CHI) is described which can be used as part of a protocol for high-throughput (50-100 compounds/day) physicochemical property profiling for rational drug design. The index is derived from retention times (t(R)) observed in a fast gradient reversed-phase HPLC method. The isocratic retention factors (log k') were measured for a series of 76 structurally unrelated compounds by using various concentrations of acetonitrile in the mobile phase.
View Article and Find Full Text PDFBiochem J
April 1997
GlaxoWellcome Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, UK.
Nitric oxide synthase (EC 1.14.13.
View Article and Find Full Text PDFHelicobacter
March 1997
GlaxoWellcome Medicines Research Centre, Stevenage, Hertfordshire, United Kingdom.
Background: This study was carried out to investigate the clinical observation that the emergence of antibiotic resistance can be reduced in Helicobacter pylori if agents are administered in combination with bismuth salts.
Materials And Methods: Two H. pylori clinical isolates were grown on chocolate Columbia agar containing either ranitidine bismuth citrate (RBC) at one-half lethal concentration (8 micrograms/ml) or no drug control for 22 subcultures.
Biochem Soc Trans
August 1996
GlaxoWellcome Medicines Research Centre, Herts, U.K.